Pre-Doctoral Fellow
University of North Carolina at Chapel Hill
Disclosure(s): No financial relationships to disclose
Katie Gravagna, MSc, is a third-year infectious disease epidemiology PhD student at University of North Carolina at Chapel Hill. Katie has also joined Bristol-Myers Squibb as a Global HEOR Fellow supporting health economics and outcomes research activities in multiple myeloma with a focus on real-world evidence generation, JCA dossier preparation, and patient-reported outcome analyses. Prior to her doctoral program, she earned a BS in microbiology from the University of Minnesota and an MSc in epidemiology from McGill University. Katie previously worked as a research assistant on projects evaluating vaccination policies and uptake and tracking the global COVID-19 vaccine trial and approval landscape. As a doctoral student, Katie has helped lead trials of novel interventions to reduce hospital-acquired infections as part of the UNC Hospital Infection Prevention department. Her dissertation continues this work by evaluating the UNC Hospital central line-associated bloodstream infection (CLABSI) prevention bundle components across hospital units and sutdying risk factors for CLABSI at the patient level.